ARCA biopharma, Inc. (ABIO) stock declined over -0.40% intraday to trade at $2.49 a share on NASDAQ. The stock opened with a gain of 3.75% at $2.48 and touched an intraday high of $2.53, falling -0.40% against the last close of $2.5. The stock went to a low of $2.407 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
ARCA biopharma, Inc. (NASDAQ: ABIO) stock price is $2.49 as of the last check on Thursday, June 30. During the trading session, ABIO stock reached the peak price of $2.53 while $2.407 was the lowest point it dropped to.
The NASDAQ listed ABIO is part of Biotechnology industry that operates in the broader Health Care sector. ARCA biopharma, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases.
Dr. Michael R. Bristow M.D., Ph.D.
Co-Founder, Pres, CEO & Director
Mr. Thomas A. Keuer
Chief Operating Officer
Mr. Christopher D. Ozeroff
Sr. VP, Gen. Counsel & Sec.
Mr. C. Jeffrey Dekker CPA
Chief Financial Officer
ABIO stock traded closed the last session at $2.49, which is $-0.01 or -0.40% lower than its previous close of $2.5. ABIO's current trading price is 45.61% lower than its 52-week high of $3.84 where as its distance from 52-week low of 1.71% is -35.16%.
Number of ABIO employees currently stands at -. ABIO operates from 10170 Church Ranch Way, Suite 100, Westminster, CO 80021, United States.
Official Webiste of $ABIO is: https://www.arcabio.com
ABIO stock volume for the day was 41,316 shares while in the previous session number of ABIO shares traded was 41,276 . The average number of ABIO shares traded daily for last 3 months was 118.74 Thousands.
The percentage change in ABIO stock occurred in the recent session was -0.40% while the dollar amount for the price change in ABIO stock was $-0.01.
In the recent session, the day high for ABIO stock was $2.53 while the low for ABIO stock touched on the day was $2.407.
The market value of ABIO currently stands at 37.1 Million with its latest stock price at $2.49 and 14.41 Million of its shares outstanding.